FDA approves Invokana for use in patients with type 2 diabetes and diabetic kidney disease Oct. 1, 2019
FDA approves Rituxan for pediatric granulomatosis with polyangiitis and microscopic polyangiitis Sep. 30, 2019
Crysvita approved in Japan for FGF-23-related hypophosphatemic rickets and osteomalacia Sep. 23, 2019
RSS